Gemina Laboratories Ltd. (TSE:GLAB) has released an update.
Gemina Laboratories Ltd. has successfully secured $910,000 through a non-brokered private placement of convertible notes, designed to bolster the company’s general working capital and corporate initiatives. With no additional compensation given for the placement, these notes are subject to a four-month hold period expiring on July 19, 2024. Gemina Laboratories, known for its innovative biosensor and diagnostic technologies, continues to advance its testing platforms for various human health pathogens.
For further insights into TSE:GLAB stock, check out TipRanks’ Stock Analysis page.
